$ARDX
Ardelyx, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Fremont, CA
ARDX chart
What traders are saying about $ARDX
Latest postsArdelyx, Inc. news
- ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
GlobeNewswire ·
- Ardelyx, Inc. (NASDAQ:ARDX) SHAREHOLDER ALERT:
GlobeNewswire ·
- Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the
GlobeNewswire ·
- Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
WBOC TV ·
- ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%?
Stocktwits ·
- Ardelyx (ARDX) Stock Could Trade Below Fair Value After Lawsuit Filing
Simply Wall Street ·
- Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders
Yahoo Finance ·
- Ardelyx Inc (41X.HM) Analyst insights, Price targets and Recommendations
Yahoo Finance Australia ·
- ARDX Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Ardelyx, Inc. Securities Class Action - Contact SueWallSt
PR Newswire ·
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX
PR Newswire ·
- ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ardelyx, Inc.
GlobeNewswire ·
- Ardelyx (ARDX) Faces Securities Class Action
STL.News ·
Ardelyx, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $407.3M | $333.6M | $124.5M | $52.2M |
| Net income | -$62.0M | -$39.0M | -$66.0M | -$67.0M |
| Diluted EPS | $-0.26 | $-0.17 | $-0.30 | $-0.42 |
| Total assets (year end) | $501.6M | $435.8M | $297.6M | $190.1M |
| Cash and equivalents (year end) | $68.0M | $64.9M | $21.5M | $96.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ardelyx, Inc.
- Ticker
- ARDX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Fremont, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1437402
- Former names
- NTERYX INC
Frequently asked questions
What exchange is Ardelyx, Inc. listed on?
Ardelyx, Inc. trades on the Nasdaq under the ticker symbol ARDX.
What industry is Ardelyx, Inc. in?
Ardelyx, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Ardelyx, Inc. headquartered?
Ardelyx, Inc.'s business address on file with the SEC is in Fremont, CA.
When does Ardelyx, Inc.'s fiscal year end?
Ardelyx, Inc.'s fiscal year ends on December 31.
How much revenue did Ardelyx, Inc. report?
Ardelyx, Inc. reported $407.3M in revenue for calendar year 2025, according to its SEC filings.